Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies
Squamous cell carcinoma of the anal canal (SCCA) is a rare neoplasm, but with rising incidence rates in the past few decades; it is etiologically linked with the human papillomavirus (HPV) infection and is especially prevalent in immunocompromised patients, mainly those infected with HIV. Fluoropyri...
Main Authors: | Maria Cecília Mathias-Machado, Renata D’Alpino Peixoto, Camila Motta Venchiarutti Moniz, Alexandre A. Jácome |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/8/2029 |
Similar Items
-
Outcomes of squamous cell carcinoma of the anal canal: A retrospective observational study from a regional cancer institute in South India
by: M N Arunkumar, et al.
Published: (2023-01-01) -
Year in Review 2018 by the Brazilian Gastrointestinal Tumors Group - GTG: Gastrointestinal Tumors
by: Anelisa K. Coutinho, et al.
Published: (2019-01-01) -
A study of microRNAs as new prognostic biomarkers in anal cancer patients
by: Olav Dahl, et al.
Published: (2024-06-01) -
Editorial: New understandings and research in anal squamous cell carcinoma
by: Stefano Kim, et al.
Published: (2023-01-01) -
mRNA Detection in Anal Cytology: A Feasible Approach for Anal Cancer Screening in Men Who Have Sex with Men Living With HIV
by: Marta Del Pino, et al.
Published: (2019-11-01)